Cutera Osake

Cutera P/CF

Delisted

P/CF (Hinta-kassavirta-suhde) yhtiöstä Cutera (CUTRQ) 9.9.2026 päivämäärällä on −0,00. Edellisenä vuonna P/CF (Hinta-kassavirta-suhde) oli −0,00 — muutos −51,40 % (korkeampi).

P/CF

−0,00

YoY

−51,40%

Viimeksi päivitetty:

P/CF (Hinta-kassavirta-suhde) yhtiöstä Cutera on 2026 −0,00 . P/CF (Hinta-kassavirta-suhde) yhtiöstä Cutera oli 2025 −0,00 . Se laskee −51,40% korkeampi edelliseen vuoteen verrattuna.

Cutera P/CF historia

  • 3 vuotta

  • 10 vuotta

  • 25 vuotta

  • Maksimi

P/CF
Date
P/CF
1.1.2016
0,09 USD
1.1.2017
0,01 USD
1.1.2018
0,55 USD
1.1.2019
−0,08 USD
1.1.2020
−0,01 USD
1.1.2021
0,14 USD
1.1.2022
−0,00 USD
1.1.2023
−0,00 USD
Cutera P/CF historia
VUOSIP/CFYoY
−0,00−51,40%
−0,00−101,85%
0,14−1 465,32%
−0,01−86,89%
−0,08−113,96%
0,55+4 509,68%
0,01−86,07%
0,09−168,34%
−0,13+215,44%
−0,04
Access this data via the Eulerpool API

Cutera Osakeanalyysi

Mitä Cutera tekee? Cutera Inc. is a leading company in the field of aesthetic and medical laser technology. The company was founded in California in 1998 and has since had a successful history in the beauty and medical care industry. Cutera's business model consists of developing and selling innovative laser devices used in the cosmetics and medical industries. The company's goal is to offer its customers (doctors, beauty clinics, etc.) the latest and most effective laser technologies to meet the needs and expectations of their patients. In recent years, Cutera has focused on several areas to offer its customers a wider range of products. These include skin rejuvenation, body contouring, hair removal, vascular and pigmented lesions, scar treatment, and tattoo removal. The company has over 20 different products in its portfolio, all tailored to the needs of different patient groups. In the field of skin rejuvenation, Cutera offers variants such as Laser Genesis Plus, Genesis V, Excel HR, and other lasers to treat wrinkles, fine lines, pigment irregularities, and texture problems. Body contouring is made possible through devices such as Sculpture and TruSculpt 3D. Hair removal is supported by the ProWave, CoolGlide, and XEO system. Treatment of vascular and pigmented lesions is done through devices such as Excel HR, LimeLight, and the XEO system. For scar treatment and tattoo removal, lasers such as Enlighten and Genesis V are used. Cutera has gained an excellent reputation in the industry through its innovative products and sustainable business philosophy. The company aims to meet the needs and expectations of its customers by providing innovative technologies, high-quality products, and outstanding customer service. Cutera continually invests in research and development to ensure that it can always offer its customers the latest and best laser devices. Additionally, the company places great importance on the safety of its products and has specialized in training and education for its customers and users. Recently, Cutera Inc. has also made strides in telemedicine to better support its customers. This allows doctors and users to access support anytime and anywhere, for example, for training and technical support. In summary, Cutera Inc. is a leading company in the field of aesthetic and medical laser technology. Its wide range of products tailored to the different needs and expectations of patients has earned it an excellent reputation in the industry. Cutera continuously invests in research and development, offers outstanding customer service, and places great importance on the safety of its products. In the future, the company will continue to develop innovative technologies, revolutionizing beauty and medical care. Cutera on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset Cutera osakkeesta

Yhtiön Cutera P/CF (Hinta-kassavirta-suhde) on −0,00 vuonna 2026.

P/CF (Hinta-kassavirta-suhde) yhtiöstä Cutera muuttui arvosta −0,00 arvoon −0,00, mikä edustaa −51,40 % muutosta. Arvo on korkeampi kuin edellisenä vuonna.

Eurpoolissa voit löytää P/CF (Hinta-kassavirta-suhde) Cutera:n täydellisen historiallisen kehityksen vuodesta 2006 lähtien – vuotuisten arvojen, kaavioiden ja yksityiskohtaisen analyysin kanssa.

Hinta-kassavirta-suhde mittaa osakekurssia suhteessa operatiiviseen kassavirtaan per osake. Toisin kuin P/E-suhde, sitä on vaikeampi manipuloida, koska kassavirta on vähemmän altis kirjanpitomuutoksille.

P/CF = Osakekurssi / Operatiivinen kassavirta per osake

Arvioidakseen P/CF (Hinta-kassavirta-suhde):n, on olennaista verrata sitä saman alan ja sektorin kilpailijoihin. Eulerpoolissa voit löytää suoria alan vertailuja P/CF (Hinta-kassavirta-suhde):lle.

"Hyvä" vaihtelee alan ja yrityksen kehitysvaiheen mukaan. Eulerpoolissa voit verrata P/CF (Hinta-kassavirta-suhde):n Cutera alan vertaisiin ja alan keskiarvoon arvioidaksesi houkuttelevuuden.

Access this data via the Eulerpool API

Arvostus — Cutera

Kaikki tunnusluvut — Cutera